Teva Pharmaceutical Industries Ltd (TEVA) — Long-term Investment Intensity
Teva Pharmaceutical Industries Ltd (TEVA) has a Long-term Investment Intensity of 0.1% as of December 2018. Long-term investments of ILA61.00 Million represent 0.1% of total assets of ILA60.68 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of Teva Pharmaceutical Industries Ltd to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Teva Pharmaceutical Industries Ltd Long-term Investment Intensity (2013–2018)
This chart shows how Teva Pharmaceutical Industries Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of December 2018, the intensity stands at 0.1%, reflecting long-term investments of ILA61.00 Million against total assets of ILA60.68 Billion ILA. Explore TEVA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Teva Pharmaceutical Industries Ltd (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Teva Pharmaceutical Industries Ltd from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see TEVA company net worth.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.1% | ILA61.00 Million | ILA60.68 Billion | ▼ 0.0 pp |
| 2017 | 0.1% | ILA83.00 Million | ILA70.61 Billion | ▼ -0.2 pp |
| 2016 | 0.3% | ILA283.00 Million | ILA92.89 Billion | ▼ -2.4 pp |
| 2015 | 2.7% | ILA1.45 Billion | ILA54.26 Billion | ▲ +2.3 pp |
| 2014 | 0.4% | ILA176.00 Million | ILA46.42 Billion | ▲ +0.0 pp |
| 2013 | 0.4% | ILA179.00 Million | ILA47.51 Billion | — |